跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CO-8
首页
药物
CO-8
CO-8
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
CRYSTALLINE FORMS OF (2R,5S,13AR)-8-HYDROXY-7,9-DIOXO-N-(2,4,6-TRIFLUOROBENZYL)-2,3,4,5,7,9,13,13A-OCTAHYDRO-2,5-METHANOPYRIDO [1',2':4,5]PYRAZINO [2,1-B][1,3]OXAZEPINE-10-CARBOXAMIDE
EP 4309736 A3
申请人: GILEAD SCIENCES INC
优先权: 2014
EP
US
WO
11 件公开
CO-CRYSTALS AND SALTS OF 8-CHLORO-N-(4-(TRIFLUOROMETHOXY)PHENYL)QUINOLIN-2-AMINE
EP 3858815 A1
申请人: ABIVAX
优先权: 2020
CN
EP
US
WO
6 件公开
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H-purin-9-yl]-1-methylcyclohexane-1-carboxamide
US 10543214 B2
申请人: CELGENE CORP
优先权: 2017
CN
US
5 件公开
N-deacetylthiocolchicine derivatives, their use and pharmaceutical formulations containing them
US 7399788 B2
申请人: INDENA SPA
优先权: 2004
US
5 件公开
Gossypol co-crystals and the use thereof
US 7342046 B2
申请人: UNIV MICHIGAN
优先权: 2005
US
5 件公开
Production method for fulvic acid solution, and fulvic acid solution
US 11111187 B2
申请人: G 8 INT TRADING CO LTD
优先权: 2017
EP
US
WO
4 件公开
Imidazolidine derivative and use thereof
US 8470829 B2
申请人: TACHIBANA KAZUTAKA
优先权: 2004
CN
US
4 件公开
NOVEL NUTRACEUTICAL AND PHARMACEUTICAL COMPOSITIONS AND USE THEREOF FOR THE TREATMENT, CO-TREATMENT OR PREVENTION OF CARTILAGE DEGRADATION OR CARTILAGE DAMAGE IN JOINTS
US 2010093843 A1
申请人: SCHWAGER JOSEPH
优先权: 2006
EP
US
WO
3 件公开
CN 101516363 A
申请人: DSM IP ASSETS BV
优先权: 2006
CN
Polymorphic forms and co-crystals of a c-Met inhibitor
US 9981988 B2
申请人: AMGEN INC
优先权: 2014
CN
US
3 件公开
Combination Therapy with Apalutamide
US 2018228790 A1
申请人: MEDIVATION TECH LLC
优先权: 2015
US
WO
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈